Theriva Biologics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $20.2M | $22.5M | $19.1M |
| FY2017 | $10.2M | $18.8M | $17.1M |
| FY2018 | $3.7M | $30.1M | $28.9M |
| FY2019 | $5.7M | $17.2M | $26.0M |
| FY2020 | $3.2M | $8.4M | $6.2M |
| FY2021 | $5.0M | $70.4M | $67.3M |
| FY2022 | $18.4M | $80.6M | $52.3M |
| FY2023 | $15.5M | $55.2M | $23.2M |
| FY2024 | $16.3M | $35.4M | $11.6M |
| FY2025 | $22.9M | $38.2M | $13.1M |